569 results on '"O'Connor, Christopher"'
Search Results
2. Training the Next Generation of Data Monitoring Committee Members: An Initiative of the Heart Failure Collaboratory
3. Clinical Trial Inclusion and Impact on Early Adoption of Medical Innovation in Diverse Populations
4. Design and Rationale for the Direct Oral Anticoagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study
5. Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection Fraction
6. Prognostic Impact of Repeated NT-proBNP Measurements in Patients With Heart Failure With Reduced Ejection Fraction
7. Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping
8. Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies: HF-ARC Expert Panel Paper
9. Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial
10. Sex-Related Differences in Patient Characteristics, Hemodynamics, and Outcomes of Cardiogenic Shock: INOVA-SHOCK Registry
11. Classification of Heart Failure Events by Severity: Insights From the VICTORIA Trial
12. Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart Failure
13. Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA
14. Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker Substudy
15. Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel
16. Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy
17. A Standardized and Regionalized Network of Care for Cardiogenic Shock
18. Sequential Evaluation of NT-proBNP in Heart Failure: Insights Into Clinical Outcomes and Efficacy of Vericiguat
19. Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction: Findings from the HF-ACTION trial
20. Medical Therapy During Hospitalization for Heart Failure With Reduced Ejection Fraction: The VICTORIA Registry
21. People's perceptions of energy technologies in an era of rapid transformation
22. Spirituality in Patients With Heart Failure
23. Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week
24. Interventions for Frailty Among Older Adults With Cardiovascular Disease: JACC State-of-the-Art Review
25. Dose-limiting, adverse event–associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial
26. Cost and Value in Contemporary Heart Failure Clinical Guidance Documents
27. The Impact of Depression on Outcomes in Patients With Heart Failure and Reduced Ejection Fraction Treated in the GUIDE-IT Trial
28. Rehabilitation Intervention in Older Patients With Acute Heart Failure With Preserved Versus Reduced Ejection Fraction
29. Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial
30. Use of Actigraphy (Wearable Digital Sensors to Monitor Activity) in Heart Failure Randomized Clinical Trials: A Scoping Review
31. Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure
32. Intercountry Differences in Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure
33. The Cost-Effectiveness of Palliative Care: Insights from the PAL-HF Trial
34. Interleukin-6 and Outcomes in Acute Heart Failure: An ASCEND-HF Substudy
35. Sex Differences in Clinical Course and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure
36. Effects of Atrial Fibrillation on Heart Failure Outcomes and NT-proBNP Levels in the GUIDE-IT Trial
37. Plasma Volume Status and Its Association With In-Hospital and Postdischarge Outcomes in Decompensated Heart Failure
38. Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF Study
39. Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory
40. Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium
41. Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation
42. N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study
43. Endpoints in Heart Failure Drug Development: History and Future
44. Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial
45. Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC: Heart Failure Position Paper
46. The Hospital Readmissions Reduction Program: Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper
47. Impact of Age on Comorbidities and Outcomes in Heart Failure With Reduced Ejection Fraction
48. Trajectories of Changes in Renal Function in Patients with Acute Heart Failure
49. Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF
50. Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.